High sensitivity C-reactive protein: Its correlation with sputum cell counts in bronchial asthma

Respiratory Medicine

Volumn 103, Issue 12, 2009, Pages 1878-1884

  Allam, Mona Hashem ^a   Said, Azza Farag ^a   El Samie Omran, Ahmed Abd ^a   Abd El Reheim, Dalia Mohammed ^a   Kasem, Ahmed Hussein ^a  

^a Minia University   (Egypt)

Author keywords

Bronchial asthma; High sensitivity C reactive protein; Pulmonary function tests; Sputum cell counts

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID;

ADULT; ARTICLE; ASTHMA; BODY MASS; CELL COUNT; CONTROLLED STUDY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; LYMPHOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; SPUTUM ANALYSIS;

ADRENAL CORTEX HORMONES; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CELL COUNT; EOSINOPHILS; EPIDEMIOLOGIC METHODS; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; HUMANS; LYMPHOCYTES; MACROPHAGES; MIDDLE AGED; NEUTROPHILS; SPUTUM; VITAL CAPACITY;

EID: 70350738335     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.06.020     Document Type: Article

References (31)

1. Pepys M.B., and Baltz M.L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 34 (1983) 141-212
2. Dong Q., and Wright J.R. Expression of C-reactive protein by alveolar macrophages. J Immunol 156 (1996) 4815-4820
3. Roberts W.L., Moulton L., Law T.C., et al. Evaluation of nine automated high sensitivity C-reactive protein methods: implication for clinical & epidemiological application. Clin Chem 47 (2001) 418-425
4. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
5. Kony S., Zureik M., Driss F., Neukirch C., Leynaert B., and Neukirch F. Association of bronchial hyper responsiveness and lung function with C-reactive protein (CRP): a population based study. Thorax 59 (2004) 892-896
6. Rifai N., Tracy R.P., and Ridker P.M. Clinical efficacy of an automated hs-CRP assay. Clin Chem 45 (1999) 2136-2141
7. National Heart, Lung and Blood Institute (NHLBI). Global initiative for asthma, global strategy for asthma management and prevention revised (GINA); 2002. p. 68-78.
8. Harik-khan R.I., Fleg J.I., and Wise R.A. Body mass index & risk of COPD. Chest 121 (2002) 370-376
9. Pin I., Gibson P.G., Kolendowicz R., Gabardo G., Denburg J.A., Hargreave F.E., et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 47 (1992) 25-29
10. Efthimiadis A., Pizzichinin E., Pizzichini M.M., and Hargreave F.E. Sputum examination for indices of airway inflammation: laboratory procedures. Eur Respir J 19 (2002) 706-708
11. Taplin L. Malignant cells in sputum. A simple method of liquefying sputum. J Med Lab Technol 23 (1966) 252
12. In: Bancrot J.D., and Gamble M. (Eds). Theory and practice of histological techniques. 5th ed. (2002), Churchill Livingstone 631-632
13. Gibson P.G., Wlodarczyk J.W., Hensley M.J., Glesson M., Henry P.L., Cripps A.W., et al. Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsivness in childhood. Am J Respir Crit Care Med 158 (1998) 36-41
14. Rifai N., and Ridker P.M. Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation. Clin Chem 49 (2003) 666-669
15. Ford E.S. Asthma, body mass index, and C-reactive protein among US adults. J Asthma 40 (2003) 733-739
16. Gan W.Q., Man S.F.P., Senthilselvan A., and Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59 (2004) 574-580
17. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., and Vignola A.M. Asthma from broncho-constriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161 (2000) 1720-1745
18. Jousilahti P., Salomaa V., and Hakala K. The association of sensitive systemic inflammation markers with bronchial asthma. Immunology 89 (2002) 381-385
19. Takemura A., Matsumoto H., Niimi A., Ueda T., Matsuoka H., Yamaguchi M., et al. High sensitivity C-reactive protein in asthma. Eur Respir J 27 (2006) 908-912
20. Anderson G.P. COPD, asthma and C-reactive protein. Eur Respir J 27 (2006) 874-876
21. Doganci A., Sauer K., Karwot R., and Finotto S. Pathological role of IL-6 in the experimental allergic bronchial asthma in mice. Clin Rev Allergy Immunol 28 (2005) 257-270
22. de Torres J.P., Cordoba-Lanus E., López-Aguilar C., de Fuentes M., de Garcini A., Aguirre-Jaime A., et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 27 (2006) 902-907
23. Nakamura H., and Yamashita T. Predictive value of cardiovascular events by high sensitivity CRP. Nippon Rinsho 60 (2002) 916-921
24. Ridker P.M. High-sensitivity C-reactive protein potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103 (2001) 1813-1818
25. Visser M., Bouter L.M., McQuillan G.M., Wener M., and Harris T. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282 (1999) 2131-2135
26. Kauffmann F., Frette C., and Annes I. Relationships of haptoglobin level to FEV1, wheezing, bronchial hyper-responsiveness and allergy. Clin Exp Allergy 21 (1991) 669-674
27. Dahl M., Tybjaerg-Hansen A., Vestbo J., Lange P., and Nordestgaard B.G. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 (2001) 1008-1011
28. Engstrom G., Lind P., Hedblad B., Wollmer P., Stavenow L., Janzon L., et al. Lung function and cardiovascular risk: relationship with inflammation sensitive plasma proteins. Circulation 106 (2002) 2555-2560
29. Gibson P.G., Simpson J.L., and Saltas N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 119 (2001) 1329-1336
30. Jayaram L., Parameswaran K., Sears M., and Hargreave F. Induced sputum cell counts: their usefulness in clinical practice. Eur Respir J 16 (2000) 150-158
31. Green R., Brightling C., Woltmann G., Parker D., et al. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 57 (2002) 875-879